During the past decade, Antalya Egitim ve Arastırma Hastanesi conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Antalya Egitim ve Arastırma Hastanesi" #1 collaborator was "Regeneron Pharmaceuticals" with 2 trials as a collaborator and "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Antalya Egitim ve Arastırma Hastanesi" are "Crohn's Disease" (2 trials), "Retinopathy of Prematurity (ROP)" (2 trials), "Ulcerative Colitis" (2 trials), "Beta-Thalassemia" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Antalya Egitim ve Arastırma Hastanesi" in a lesser frequency.

Most popular intervention types in "Antalya Egitim ve Arastırma Hastanesi" are "Drug" (11 trials), "Other" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Mirikizumab" (3 trials), "Eylea (Aflibercept, BAY86-5321)" (2 trials), "Laser photocoagulation" (2 trials) and "Anastrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Antalya Egitim ve Arastırma Hastanesi" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Antalya Egitim ve Arastırma Hastanesi". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Antalya Egitim ve Arastırma Hastanesi, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Antalya Egitim ve Arastırma Hastanesi, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".